Yale: The effort to evaluate COVID-19 vaccines in even younger children is now moving forward. Inci Yildirim, MD, PhD, associate professor of pediatrics (infectious diseases) at Yale School of Medicine, will lead Yale’s component of Moderna’s clinical trial of a vaccine for children 6 months to 12 years of age. Called KidCOVE, the phase 2/3 trial is being conducted at approximately 90 sites across the U.S. and Canada and will include 6,750 children.

No where in the article does it explain why on earth you would do that. So drug companies can expand their market? Worldwide, vaccinations of children will cause 1000's of unnecessary deaths.

Just let kids catch Covid - doesn't hurt them - provides stronger/longer-lasting immunity than a vaccine.